These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 39431199)

  • 1. Hippo Signaling Pathway in Colorectal Cancer: Modulation by Various Signals and Therapeutic Potential.
    Mohammadpour S; Torshizi Esfahani A; Sarpash S; Vakili F; Zafarjafarzadeh N; Mashaollahi A; Pardakhtchi A; Nazemalhosseini-Mojarad E
    Anal Cell Pathol (Amst); 2024; 2024():5767535. PubMed ID: 39431199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of hippo pathway in colorectal cancer.
    Liang K; Zhou G; Zhang Q; Li J; Zhang C
    Saudi J Gastroenterol; 2014; 20(3):188-94. PubMed ID: 24976283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of colorectal cancer tumorigenesis by ursolic acid and doxorubicin is mediated by targeting the Akt signaling pathway and activating the Hippo signaling pathway.
    Hu D; Meng RY; Nguyen TV; Chai OH; Park BH; Lee JS; Kim SM
    Mol Med Rep; 2023 Jan; 27(1):. PubMed ID: 36382656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the role of the Hippo pathway in cancer.
    Han Y
    J Transl Med; 2019 Apr; 17(1):116. PubMed ID: 30961610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RARγ Downregulation Contributes to Colorectal Tumorigenesis and Metastasis by Derepressing the Hippo-Yap Pathway.
    Guo PD; Lu XX; Gan WJ; Li XM; He XS; Zhang S; Ji QH; Zhou F; Cao Y; Wang JR; Li JM; Wu H
    Cancer Res; 2016 Jul; 76(13):3813-25. PubMed ID: 27325643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer.
    Pan Y; Tong JHM; Lung RWM; Kang W; Kwan JSH; Chak WP; Tin KY; Chung LY; Wu F; Ng SSM; Mak TWC; Yu J; Lo KW; Chan AWH; To KF
    Mol Cancer; 2018 Jul; 17(1):102. PubMed ID: 30037330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Hippo signaling pathway in gastric cancer.
    Cao Z; An L; Han Y; Jiao S; Zhou Z
    Acta Biochim Biophys Sin (Shanghai); 2023 Mar; 55(6):893-903. PubMed ID: 36924251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unraveling a novel hippo-associated immunological prognostic signature: The contribution of SERPINE1 in facilitating colorectal cancer progression via the notch signaling pathway.
    Su X; Wang X; Lai J; Mao S; Li H
    Genomics; 2024 Mar; 116(2):110794. PubMed ID: 38224823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the Hippo-YAP/TAZ Pathway in Epithelioid Hemangioendothelioma and its Potential as a Therapeutic Target.
    Suto H
    Anticancer Res; 2024 Oct; 44(10):4147-4153. PubMed ID: 39348982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippo pathway effectors YAP, TAZ and TEAD are associated with EMT master regulators ZEB, Snail and with aggressive phenotype in phyllodes breast tumors.
    Akrida I; Makrygianni M; Nikou S; Mulita F; Bravou V; Papadaki H
    Pathol Res Pract; 2024 Oct; 262():155551. PubMed ID: 39153238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Hippo Pathway in Cancer Stem Cell Biology.
    Park JH; Shin JE; Park HW
    Mol Cells; 2018 Feb; 41(2):83-92. PubMed ID: 29429151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TFAP2C promotes stemness and chemotherapeutic resistance in colorectal cancer via inactivating hippo signaling pathway.
    Wang X; Sun D; Tai J; Chen S; Yu M; Ren D; Wang L
    J Exp Clin Cancer Res; 2018 Feb; 37(1):27. PubMed ID: 29439714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased proton-sensing receptor GPR4 signalling promotes colorectal cancer progression by activating the hippo pathway.
    Yu M; Cui R; Huang Y; Luo Y; Qin S; Zhong M
    EBioMedicine; 2019 Oct; 48():264-276. PubMed ID: 31530502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Hippo Pathway in Prostate Cancer.
    Salem O; Hansen CG
    Cells; 2019 Apr; 8(4):. PubMed ID: 31018586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PP2A drives the stemness in colorectal cancer cells by decreasing the Hippo signaling pathway.
    Wang M; Chen T; Zhang J; Wen X
    Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):114-120. PubMed ID: 38279464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSRP2 suppresses colorectal cancer progression
    Chen L; Long X; Duan S; Liu X; Chen J; Lan J; Liu X; Huang W; Geng J; Zhou J
    Theranostics; 2020; 10(24):11063-11079. PubMed ID: 33042270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Hippo signaling pathway: from multiple signals to the hallmarks of cancers.
    Zhu N; Yang R; Wang X; Yuan L; Li X; Wei F; Zhang L
    Acta Biochim Biophys Sin (Shanghai); 2023 Mar; 55(6):904-913. PubMed ID: 36942989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SNHG14 facilitates cell proliferation in colorectal cancer through targeting KRAS via Hippo-YAP signaling.
    Shen M; Su Y; Song S; Liu D; Liu Z; Chen D; Pan Y; Zhang L; Xu X
    Cell Mol Biol (Noisy-le-grand); 2023 Mar; 69(3):64-68. PubMed ID: 37300688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hippo Signaling in Embryogenesis and Development.
    Wu Z; Guan KL
    Trends Biochem Sci; 2021 Jan; 46(1):51-63. PubMed ID: 32928629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deciphering the functional landscape and therapeutic implications of noncoding RNAs in the TGF-β signaling pathway in colorectal cancer: A comprehensive review.
    Saadh MJ; Allela OQB; Sattay ZJ; Al Zuhairi RAH; Ahmad H; Eldesoky GE; Adil M; Ali MS
    Pathol Res Pract; 2024 Mar; 255():155158. PubMed ID: 38320438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.